ArticleActa neuropathologica communications2024

Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma.

Gloria Cimaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.